Healthcare Access in Emerging Markets: The Role of Indian Manufacturers

Access to affordable, quality medicines remains one of the greatest healthcare challenges of the 21st century. In sub-Saharan Africa, Southeast Asia, and parts of Latin America, a significant proportion of the population lacks reliable access to even basic essential medicines. Indian pharmaceutical manufacturers have emerged as a critical part of the solution — supplying affordable generic medicines that align with WHO essential medicines lists while meeting international quality standards.

The Scale of the Challenge

According to the World Health Organization, approximately two billion people worldwide lack access to essential medicines. In many low- and middle-income countries (LMICs), out-of-pocket healthcare costs represent a significant portion of household expenditure, with high-priced branded medicines placing necessary treatments beyond the reach of ordinary families. The emergence of quality Indian generics has fundamentally changed this equation in many markets.

India's Contribution to Global Healthcare Access

• Antiretrovirals: Indian manufacturers supply over 90% of the antiretroviral medicines used in HIV/AIDS treatment programmes across Africa — at prices dramatically lower than originator brands.
• Antimalarials: India is the primary global supplier of artemisinin-based combination therapies (ACTs) — the frontline treatment for malaria in endemic regions.
• Vaccines: The Serum Institute of India alone produces over 1.5 billion vaccine doses annually, supplying immunisation programmes across the developing world.
• Antibiotics and pain management: Affordable formulations of essential antibiotics, NSAIDs, and analgesics from Indian manufacturers form the backbone of healthcare systems across dozens of LMICs.

The Distributor's Role in the Healthcare Access Ecosystem

Local distributors in emerging markets are the critical last-mile link in the healthcare access chain. By partnering with reliable Indian manufacturers, distributors can build supply chains for essential medicines that combine quality assurance with competitive pricing — creating sustainable businesses while genuinely contributing to public health outcomes in their communities.

Silok Pharma works with distributors across Tanzania, Ethiopia, Kenya, Cambodia, Myanmar, and multiple markets in the Middle East — providing tailored product selections, regulatory documentation, and market entry support.

Building a Long-Term Partnership

Healthcare access is not a one-time transaction — it requires consistent supply, reliable quality, and responsive after-sales support. Silok Pharma's approach to distributor partnerships emphasises long-term relationship building: understanding your market's specific disease burden, therapeutic priorities, and regulatory environment, and aligning our product portfolio and support to meet those needs effectively.